LORIN STEIN: Open Payments
NPI 1902292261 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,124 in 43 payments from 12 companies in 2025. Trend: 2023 $1,016 · 2024 $1,081 · 2025 $1,124
Food & beverage: $1,024Education: $100
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 12 | $274 |
| Insmed, Inc. | 6 | $196 |
| Astellas Pharma US Inc | 4 | $181 |
| EMD Serono, Inc. | 3 | $90 |
| Merck Sharp & Dohme LLC | 5 | $89 |
| Melinta Therapeutics, LLC | 3 | $73 |
| Paratek Pharmaceuticals, Inc. | 3 | $55 |
| ABBVIE INC. | 2 | $42 |
| Gilead Sciences, Inc. | 1 | $35 |
| Ferring Pharmaceuticals Inc. | 2 | $33 |
Products named: Arikayce, CABENUVA, DOVATO, Cresemba, Rezzayo, NUZYRA, PIFELTRO, REBYOTA.
Industry payments across SC — which companies pay providers there.
